Research programme: vaccines - GlaxoSmithKline/Synt:em
Latest Information Update: 04 Feb 2008
At a glance
- Originator Synt:em
- Class Cancer vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Infections
Most Recent Events
- 04 Feb 2008 Discontinued - Preclinical for Cancer in France (unspecified route)
- 04 Feb 2008 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 04 Feb 2008 Discontinued - Preclinical for Infections in France (unspecified route)